FUNDC1 and amyotrophic lateral sclerosis: Another study showed that FUNDC1 protein levels in ALS mice decreased slightly at 60 days (pre-symptomatic stage) and significantly at 90 days (symptomatic stage) and 120 days (terminal stage), suggesting that changes in FUNDC1 levels may be related to the progression of ALS (Guo et al., 2024).